欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3319/001
药品名称Fingolimod Pharmaselect
活性成分
    • fingolimod hydrochloride 0.5 mg
剂型Capsule, hard
上市许可持有人Pharmaselect International Beteiligungs GmbH Ernst-Melchior-Gasse 20 Leopoldstadt, 1020 Vienna Austria
参考成员国 - 产品名称Denmark (DK)
Fingolimod Pharmaselect
互认成员国 - 产品名称
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Ireland (IE)
    • Austria (AT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Areleptan
    • Hungary (HU)
      Fingolimod Pharmaselect 0,5 mg kemény kapszula
    • Bulgaria (BG)
      Fingolimod Pharmaselect
    • Czechia (CZ)
      Fingolimod Pharmaselect 0,5 mg tvrdé tobolky
许可日期2023/12/13
最近更新日期2023/12/14
药物ATC编码
    • L04AA27 fingolimod
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase